Live from the NIH registry
Studies recruiting near Cincinnati right now
Top 25 of 1,127 recruiting studies, sorted by proximity — each links to its official registry page
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Cincinnati Eye Institute — Blue Ash, Ohio (9.3 mi)
· Sponsor: Genentech, Inc.
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: Nationwide Children's Hospital
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Oncology Hematology Care Clinical Trials LLC — Cincinnati, Ohio (1.1 mi)
· Sponsor: Regeneron Pharmaceuticals
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
University of Cincinnati Medical Center ( Site 0156) — Cincinnati, Ohio (1.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Good Samaritan Hospital - Cincinnati — Cincinnati, Ohio (1.1 mi)
· Sponsor: SWOG Cancer Research Network
BE WELL With Migraine: Brain Education and WELLness With Migraine
Migraine
N/A
Interventional 286 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: Wake Forest University Health Sciences
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG
Phase 2
Interventional 60 participants sought
Cincinnati Children's Hospital — Cincinnati, Ohio (1.1 mi)
· Sponsor: Nationwide Children's Hospital
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Cincinnati, Ohio (1.1 mi)
· Sponsor: Sameek Roychowdhury
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
Mercy Health — Cincinnati, Ohio (1.1 mi)
· Sponsor: Magenta Medical Ltd.
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
Cardiomyopathies, Heart Failure
N/A
Interventional 300 participants sought
TriHealth Hatton Research Institute — Cincinnati, Ohio (1.1 mi)
· Sponsor: Zoll Medical Corporation
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
Cytomegalovirus (CMV)
Phase 3
Interventional 80 participants sought
Cincinnati Children's Hospital Medical Center - PIN — Cincinnati, Ohio (1.1 mi)
· Sponsor: Takeda
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
Systemic Lupus Erythematosus of Childhood (Disorder)
N/A
Interventional 175 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: Michigan State University
Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents
Bipolar Disorder (BD), Bipolar Disorder NOS
N/A
Interventional 80 participants sought
University of Cincinnati College of Medicine — Cincinnati, Ohio (1.1 mi)
· Sponsor: University of California, Los Angeles
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Cincinnati, Ohio (1.1 mi)
· Sponsor: AstraZeneca
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Arthritis and Rheumatology of Southwest Ohio — Liberty Township, Ohio (19.0 mi)
· Sponsor: University of Alabama at Birmingham
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
University of Cincinnati Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: Nurix Therapeutics, Inc.
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Heavy Menstrual Bleeding
N/A
Interventional 7 participants sought
Seven Hills Clinical Research Group, LLC — Cincinnati, Ohio (1.1 mi)
· Sponsor: Rejoni Inc.
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Phase 3
Interventional 180 participants sought
Univ of Cincinnati Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Narcolepsy Type 1
Phase 3
Interventional 150 participants sought
Alkermes Investigational Site — Cincinnati, Ohio (1.1 mi)
· Sponsor: Alkermes, Inc.
Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)
Breast Cancer, Surgery
N/A
Interventional 6 participants sought
University of Cincinnati — Cincinnati, Ohio (1.1 mi)
· Sponsor: University of Cincinnati
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
Phase 2, Phase 3
Interventional 300 participants sought
GSK Investigational Site — Cincinnati, Ohio (1.1 mi)
· Sponsor: GlaxoSmithKline
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
University of Cincinnati Cancer Center-UC Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: NRG Oncology
Clinical Course Of Disease In Participants With FA-CM
Friedreich Ataxia, Cardiomyopathy
N/A
Observational 65 participants sought
Cincinnati Children's Hospital — Cincinnati, Ohio (1.1 mi)
· Sponsor: Lexeo Therapeutics
Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)
Complex Cardiovascular Surgery With Cardiopulmonary Bypass
Phase 3
Interventional 200 participants sought
University of Cincinnati — Cincinnati, Ohio (1.1 mi)
· Sponsor: CSL Behring